White Mark Andrew 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Nov 4, 2024
Insider Transaction Report
Form 4
White Mark Andrew
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-10-31$16.63/sh−3,080$51,205→ 69,140 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.